Use of 5-Alpha-Reductase Inhibitors Did Not Increase the Risk of Cardiovascular Diseases in Patients with Benign Prostate Hyperplasia: A Five-Year Follow-Up Study-Reference-Cited by-同舟云学术

Use of 5-Alpha-Reductase Inhibitors Did Not Increase the Risk of Cardiovascular Diseases in Patients with Benign Prostate Hyperplasia: A Five-Year Follow-Up Study

Published:2015-03-24 Issue:3 Volume:10 Page:e0119694
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Hsieh Teng-Fu,Yang Yu-Wan,Lee Shang-Sen,Lin Tien-Huang,Liu Hsin-Ho,Tsai Tsung-Hsun,Chen Chi-Cheng,Huang Yung-Sung,Lee Ching-Chih

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference29 articles.

1. Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard?;J Silva;Current opinion in urology,2014

2. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction;M Oelke;European urology,2013

3. Update on AUA guideline on the management of benign prostatic hyperplasia;KT McVary;The Journal of urology,2011

4. Androgen metabolism in men receiving finasteride before prostatectomy;RW Norman;The Journal of urology,1993

5. Validation of a population pharmacokinetic/pharmacodynamic model for 5 alpha-reductase inhibitors;P Olsson Gisleskog;European journal of pharmaceutical sciences: official journal of the European Federation for Pharmaceutical Sciences,1999

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential Association Between Cumulative Dose of 5α-Reductase Inhibitors and Mortality;2024-07-08

2. Design of Liposome Formulations for CRISPR/Cas9 Enzyme Immobilization: Evaluation of 5-Alpha-Reductase Enzyme Knockout for Androgenic Disorders;ACS Omega;2023-11-20

3. Targeting galectin-3 in inflammatory and fibrotic diseases;Trends in Pharmacological Sciences;2023-08

4. 5-alpha reductase inhibitors use in prostatic disease and beyond;Translational Andrology and Urology;2023-03

5. Static and dynamic component of obstruction in benign prostatic hyperplasia;Galenika Medical Journal;2022